Learn more about the latest advances from Cedars-Sinai investigators.
Transcatheter aortic valve replacement (TAVR) is a minimally invasive procedure used to replace damaged heart valves, offering patients an alternative to open heart surgery.
A research team reveals the promising antihypertensive effects of egg white hydrolysates (EWH) and ovotransferrin-depleted egg white hydrolysates (OD-EWH) in spontaneously hypertensive rats (SHRs), suggesting that these natural ingredients could be effective alternatives to traditional pharmaceuticals for managing hypertension.
Erythritol, a commonly used sugar substitute often marketed as 鈥渉ealthy,鈥� may impair blood vessel health by disrupting the brain鈥檚 ability to produce a critical compound, according to new research. Scientists will present their findings at the 2025 American Physiology Summit in Baltimore. The Summit is the flagship annual meeting of the American Physiological Society (APS).
Statins are lifesaving to those with high cholesterol, but patients don鈥檛 always take them. A nudge that increased long-term prescriptions could be key
A new collaboration between the University of Michigan and Stanford University aims to give stroke patients the ability to "speak" by detecting and interpreting brain signals, using the world's smallest computers linked up to the world's most biocompatible sensors.
Results presented during oral presentation at the American Academy of Neurology 2025 Annual Meeting
Cervical artery dissection is a tear in an artery in the neck that provides blood flow to the brain. Such a tear can result in blood clots that cause stroke. A new study has found almost a five-fold increase in the number of U.S. hospitalizations for cervical artery dissection over a 15-year period. The study is published on April 2, 2025, online in Neurology庐, the medical journal of the American Academy of Neurology (AAN).
Recent guidelines have restricted aspirin use for primary cardiovascular disease prevention, with the AHA/ACC restricting it to patients under 70 and the U.S. Preventive Services Task Force further restricting it to those under 60, even though heart attack and stroke risks increase with age. Researchers argue they were overly influenced by the flawed ASPREE trial, which failed to provide reliable evidence of aspirin鈥檚 efficacy in the enrolled age groups, and that proper statistical principles must guide trial design, analysis, and interpretation to avoid misleading conclusions.
South Africa鈥檚 2013 sodium reduction law is lowering blood pressure and improving health. A study by Wits & Harvard found a 10% drop in sodium intake, with stricter limits in processed foods. Even small reductions cut heart disease risk. Experts say more countries should follow suit. #PublicHealth
Stroke survivors who have attended some level of higher education may face even steeper mental declines, according to a study led by Michigan Medicine. The findings suggest that attending higher education may enable people to retain greater cognitive ability until a critical threshold of brain injury is reached after a stroke.
Ochsner Health Medical Director for Cardiac Rehabilitation and Preventive Cardiology, Carl J. 鈥淐hip鈥� Lavie, Jr., MD, recently co-authored a groundbreaking research study featured in the prestigious Mayo Clinic Proceedings highlighting the comparative efficacy of lipid-lowering therapies for reducing cardiovascular risks and led by Maciej Banach, MD,PhD from Poland and leader of the International Lipid Expert Panel ( ILEP).
An imbalance in ligands, which are molecules produced by the body and the gut microbiota, can affect a key receptor protein that plays a role in brain inflammation after stroke, according to researchers at UTHealth Houston, who recently published their preclinical findings in Nature Communications.
A new study by UCLA Health has discovered what researchers say is the first drug to fully reproduce the effects of physical stroke rehabilitation in model mice, following from human studies.
A stem cell therapy trial aimed at reducing neuroinflammation in patients with presymptomatic Alzheimer鈥檚 disease is underway at UTHealth Houston.
A clot-busting drug recently approved to treat acute ischemic strokes (AIS) that can be delivered quickly works as well as a decades-old medication used by most hospitals in the U.S. and could hold significant advantages for some patients, a study led by a UT Southwestern Medical Center researcher shows. The findings, published in JAMA Network Open, could encourage more hospitals to use the newer drug, tenecteplase.
A study published March 6 in The Lancet Regional Health 鈥� Americas highlights a growing divide in cardiovascular health in the U.S., showing that wealth and education play a significant role in heart disease risk.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal 蜜桃传媒 keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right